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From exercise intolerance to functional
improvement: the second wind phenomenon in
the identification of McArdle disease
De intolerância ao exercício à melhora funcional: o fenômeno second wind na identificação
da doença de McArdle
Renata Siciliani Scalco1,2,3, Sherryl Chatfield1, Richard Godfrey1,4, Jatin Pattni1, Charlotte Ellerton1,
Andrea Beggs1, Stefen Brady1, Andrew Wakelin5, Janice L Holton1, Ros Quinlivan1
ABSTRACT
McArdle disease is the most common of the glycogen storage diseases. Onset of symptoms is usually in childhood with muscle pain and
restricted exercise capacity. Signs and symptoms are often ignored in children or put down to ‘growing pains’ and thus diagnosis is often
delayed. Misdiagnosis is not uncommon because several other conditions such as muscular dystrophy and muscle channelopathies can
manifest with similar symptoms. A simple exercise test performed in the clinic can however help to identify patients by revealing the
second wind phenomenon which is pathognomonic of the condition. Here a patient is reported illustrating the value of using a simple 12
minute walk test.
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RESUMO
A doença de McArdle é o tipo mais frequente das glicogenoses. A apresentação clínica característica na infância inclui mialgia e
intolerância aos esforços/exercício físico. Frequentemente, os sinais e sintomas das crianças não são considerados devidamente, sendo
muitas vezes interpretados como “dores do crescimento”, retardando o diagnóstico. Erros diagnósticos não são raros uma vez que outras
doenças, como distrofia muscular ou canalopatias musculares, podem apresentar sintomas semelhantes. Entretanto, um simples teste
de exercício físico realizado no ambulatório/consultório médico pode ajudar a identificar estes pacientes pois evidencia o fenômeno
second wind, patognomônico da doença de McArdle. Aqui é descrito um relato de caso de um paciente ilustrando o valor do simples 12
minutes walk test.
Palavras-chave: doença de McArdle, doença de depósito do glicogênio tipo V, fenomeno de second wind, teste do exercício, teste 12
minutos de marcha.
McArdle disease or glycogen storage disease type V (mus-
cle phosphorylase deficiency, glycogenosis Type V) is a rare
autosomal recessive metabolic myopathy with significant
molecular heterogeneity caused by homozygous or com-
pound heterozygous mutations in the muscle glycogen
phosphorylase gene (PYGM) located at chromosome
11q131,2. It is the most common glycogen storage disorder
affecting muscle, with an estimated prevalence of
1:100,000-1:167,0003,4. The disorder is caused by deficiency
of the enzyme muscle glycogen phosphorylase which cata-
lyzes the degradation of glycogen into glucose subunits.
Enzyme deficiency can be demonstrated in frozen muscle
sections using enzyme histochemistry: muscle fibres show
absent phosphorylase activity while the activity is preserved
in smooth muscle in the walls of blood vessels due to the
expression of the brain isoform, which is expressed by a
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different gene (Figure 1). The inability to metabolise gly-
cogen results in severe impairment of physical activity that
is dependent on anaerobic glycolysis. Consequently, people
with this condition will experience exercise intolerance dur-
ing the first minutes of physical activity, represented by
fatigue, pain and weakness; and throughout more intense
or isometric activity. A contracture, or severe muscle cramp
causing rigidity, occurs due to the lack of muscle energy sub-
strate during intense exercise and leads to muscle damage
and myoglobinuria.
Despite its rarity, it is important for doctors to be
familiar with the condition because early diagnosis and
the adoption of an appropriate lifestyle may help in
improving quality of life and prevent severe life-threatening
complications such as compartment syndrome, acute rhab-
domyolysis and acute renal failure. Unfortunately, there is
often a delay in diagnosing McArdle disease and affected
individuals may be misdiagnosed with other disorders such
as polymyositis and chronic fatigue syndrome5,6. The second
wind phenomenon, as described in a 12 minute walking test
and 15 minute cycle test, is known to be pathognomonic
for McArdle disease and its identification in the clinic can
aid diagnosis.
Here we present a case of a patient with a history of exer-
cise intolerance with immediate increase in exercise capa-
city and illustration of the second wind phenomenon
during a 12 minute walk test (12MWT).
CASE REPORT
A 50 year-old-man was referred for neuromuscular evalu-
ation some 20 years after being diagnosed with McArdle dis-
ease. From his medical history it was clear that he had
problems with exercise since he was a child. He had never
been able to run and symptoms such as myalgia and exer-
cise intolerance had always been severe enough to disrupt
any physical activity undertaken since the age of 4. Muscle
cramps in his legs were the most common feature. He was
reprimanded by his schoolteachers in physical education
classes and learnt to avoid sports such as football. He gave
up swimming having almost drowned on two occasions.
However, despite these early problems, he remained active
choosing activities he could do at his own pace including
a daily newspaper delivery round. He found that he could
even complete day-long hikes and felt better at the end than
at the beginning of activities.
Many attempts at diagnosis were rebuffed by family doc-
tors and local specialists. He was resigned to simply having
what he called “bad legs”, but at age 16 a canoeing expedi-
tion led to bilateral contractures affecting his upper limbs
which led to myoglobinuria. He was diagnosed with gout
at age 19, despite no obvious risk factors. Over the years
he suffered several episodes of rhabdomyolysis but hospital
admission resulted only in pain medication and no dia-
gnostic investigation. It was finally a rheumatologist treating
his gout 10 years later who listened to his story and carried
out a baseline serum creatine kinase (CK) test. The abnor-
mal result (1223 IU/L) led to neurophysiology evaluation,
forearm exercise test, urine test for myoglobin and finally a
diagnostic muscle biopsy. He received little information
about his condition and no follow up until he was referred
by his GP to a specialized clinic at age 50. At that time, gen-
etic testing demonstrated homozygous mutations at R50X in
the PYGM gene, confirming the diagnosis.
On interview at 50 years of age, it was clear that whilst he
had no knowledge of the second wind phenomenon he had
in fact been using it since childhood. During the 12MWT
performed at clinic, an increase in his heart rate (HR) was
associated with leg discomfort during the first minutes of
activity, with improvement of both symptoms occurred at
around 7-8 minutes (Table 1). Thereafter he was able to con-
tinue exercise with improvement in his symptoms. The clear
demonstration of such second wind phenomenon during the
12 MWT, and a discussion of the timings and mechanisms
involved, has enabled him to make more confident in his
Figure 1. Illustrations of key pathological features. Skeletal muscle shows features of a vacuolar myopathy on H&E (A). There is a
marked increase in glycogen content within vacuoles on the PAS preparation (B). Muscle fibres show reduced phosphorylase
activity (C) while the activity is preserved in smooth muscle in the walls of blood vessels (arrows). The bar represents 50mm in
all panels.
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physical abilities using this phenomenon, thus improving his
quality of life substantially.
DISCUSSION
The case reported above describes the typical clinical pic-
ture of McArdle disease: exercise intolerance, myalgia,
cramps and episodes of myoglobinuria/rhabdomyolysis. A
carefully taken history is essential to diagnose this condition.
Exercise intolerance usually starts during the first few min-
utes of physical activity and is described as muscle pain, dis-
comfort, stiffness, cramps, fatigue and/or exhaustion2,4,6,7. It
is commonly associated with dyspnoea and tachycardia.
Triggers for exercise intolerance include any kind of skeletal
muscle activity, particularly anaerobic activity as this is
dependent on muscle energy from glycogenolysis8. There is
an increased risk of myoglobinuria and rhabdomyolysis if
activities are continued in the presence of these symptoms.
Fixed weakness affecting the paraspinal and upper limb
muscles may occur. Muscle hypertrophy can also be seen
in a proportion of patients4,6,9.
The finding of a raised serum CK in combination with
exercise intolerance should raise suspicion of a metabolic
myopathy. Although these features may also be seen in other
conditions such as other metabolic myopathies, muscular
dystrophies and muscle channelopathies, the “trick of the
trade” here is the identification of the second wind phenom-
enon during the walking test. The second wind is a period of
less painful and more effective exercise after the initial per-
iod of muscle cramps. This was first observed and reported
by Pearson et al11. and is recognised as a sudden improve-
ment in exercise tolerance associated with a decrease in
pain, HR and dyspnoea following an initial abnormal
increase in these parameters10,11,12. This phenomenon usually
occurs after 6-8 minutes of exercise, during which time
exercise is often slowed in pace and/or interrupted by short
rests to manage the pain. Once in the second wind, people
with McArdle Disease can continue to exercise with ameli-
oration of their symptoms.
The second wind phenomenon appears to represent
the lag that exists in supplying sufficient energy for physical
activity as a result of deficient glycolytic muscle metabolism
and the time taken for the release of glucose from liver
glycogen stores and fatty acid oxidation to provide the
required energy. It is pathognomonic of McArdle disease
and is present in 100% of patients with this condition13.
Consequently, identifying the second wind helps with the
clinical assessment and diagnostic process.
Although the second wind phenomenon is present in all
cases of McArdle disease, some patients may have difficulty
in recognizing and eliciting the phenomenon in themselves
during everyday physical activity4,6. Consequently, they may
not volunteer it in the clinical history even if it is specifically
asked for. Performing an exercise test to reproduce the phe-
nomenon in a clinic setting may not only help with the dia-
gnostic process for McArdle disease but also be used to
demonstrate the phenomenon to patients from a thera-
peutic perspective. There are two exercise tests that elicit
the second wind phenomenon in McArdle disease, namely
12 minute walk test (12 MWT)6 and cycle test13. The 12
MWT is a simple, easy, non-invasive assessment that can
be performed in any clinical setting6. The test is carried
out on a treadmill or in a corridor on a marked 10m length.
During this self-paced test the patient completes as many
10m shuttle walks as possible in the 12 minutes. HR and
symptoms are monitored each minute during the test, the
latter being assessed by the Borg Rating of Perceived Pain
(RPP) scale (Table 1)14. During the test, the HR and symp-
toms (pain/weakness) initially increase, followed by a reduc-
tion in both parameters after 5-10 minutes of physical
activity. Likewise, the cycle test demonstrates a similar pat-
tern in HR and symptoms during 15 minutes of cycling at a
constant, moderate workload13; however, this test requires
Table 1.12-minute walk test. During the test, an increase in HR was associated with left leg (thigh more than calf) discomfort
during the first 6 minutes of activity, which made him reduce his pace. The patient achieved the second wind following 7-8
minutes of activity, when his symptoms and HR reduced without changing the walking speed.
Time Walking speed Distance covered (m) Heart rate Borg Pain Rating
1 - 55 90 0
2 - 120 95 1
3 Slowed down 180 100 2
4 - 240 109 3
5 Slowed down 290 108 3
6 - 344 113 2.5
7 - 404 116 2
8 - 460 111 1.5
9 - 530 111 1.5
10 - 590 106 1
11 - 664 107 0.5
12 - 730 104 0
Resting heart rate: 67; Baseline symptoms: none; Distance completed: 730 m.
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a cycle ergometer which may not be available in a
clinical setting.
Exercise tests are useful for collecting data which can be
used to monitor improvement from one clinic visit to the next.
They can also be used to train patients to get into the second
wind in every-day situations, thus improving quality of life.
In summary, here we report the importance of identifying
the second wind phenomenon when assessing patients with
exercise intolerance (Table 2). This phenomenon is unique
to McArdle disease and should guide the diagnostic process.
The 12 MWT is easy to perform during the clinical assess-
ment with no significant financial impact and demonstrates
the presence of the second wind phenomenon. It should be
performed as a routine evaluation tool to guide genetic or
histopathology tests for McArdle disease. It also helps both
in terms of collecting data, which can be used to monitor
improvement from one clinic visit to the next, but also in
training patients to recognize their own symptoms.
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Table 2. Learning points of the second wind phenomenon.
Learning Points
The second wind is a period of less painful and more effective exercise associated with a decrease in heart rate after the initial period of
cramping and/or weakness.
The second wind phenomenon is a hallmark for McArdle Disease.
Performing an exercise test during clinic evaluation can confirm the presence of the second wind phenomenon.
Some patients may require exercise test and training to help them recognize when they achieve the second wind.
Exercise tests can be used to train patients to get into the second wind in every-day situations, thus improving quality of life.
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